- Home
- PTEN vs VKTX Comparison
PTEN vs VKTX Comparison
Compare PTEN & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTEN
- VKTX
- Stock Information
- Founded
- PTEN 1978
- VKTX 2012
- Country
- PTEN United States
- VKTX United States
- Employees
- PTEN N/A
- VKTX N/A
- Industry
- PTEN Oil & Gas Production
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- PTEN Energy
- VKTX Health Care
- Exchange
- PTEN Nasdaq
- VKTX Nasdaq
- Market Cap
- PTEN 2.3B
- VKTX 2.8B
- IPO Year
- PTEN 1993
- VKTX 2015
- Fundamental
- Price
- PTEN $5.76
- VKTX $26.61
- Analyst Decision
- PTEN Buy
- VKTX Buy
- Analyst Count
- PTEN 13
- VKTX 12
- Target Price
- PTEN $9.92
- VKTX $84.00
- AVG Volume (30 Days)
- PTEN 13.4M
- VKTX 2.8M
- Earning Date
- PTEN 07-23-2025
- VKTX 07-23-2025
- Dividend Yield
- PTEN 5.56%
- VKTX N/A
- EPS Growth
- PTEN N/A
- VKTX N/A
- EPS
- PTEN N/A
- VKTX N/A
- Revenue
- PTEN $5,148,088,000.00
- VKTX N/A
- Revenue This Year
- PTEN N/A
- VKTX N/A
- Revenue Next Year
- PTEN $0.40
- VKTX N/A
- P/E Ratio
- PTEN N/A
- VKTX N/A
- Revenue Growth
- PTEN 5.82
- VKTX N/A
- 52 Week Low
- PTEN $5.12
- VKTX $18.92
- 52 Week High
- PTEN $11.27
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- PTEN 46.06
- VKTX 47.73
- Support Level
- PTEN $5.38
- VKTX $26.66
- Resistance Level
- PTEN $5.87
- VKTX $28.33
- Average True Range (ATR)
- PTEN 0.24
- VKTX 1.34
- MACD
- PTEN 0.01
- VKTX -0.21
- Stochastic Oscillator
- PTEN 36.89
- VKTX 25.31
About PTEN Patterson-UTI Energy Inc.
Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.